Fingerprint
Dive into the research topics of 'A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically